People · Operator
Named in public records as an officer, director or promoter · active 2016–2019 · Biotechnology, Pharma, Agriculture
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Metagenomi Technologies, LLC | — | Biotechnology | Series D+ | $345.1M | $1.7B | 2019 |
| Pyxis Oncology, Inc. | — | Pharma | Series D+ | $194.5M | $5.0B | 2019 |
| CoverCress Inc. | — | Agriculture | Series B | $36.7M | $184.8M | 2018 |
| Myotherix, Inc. | — | Biotechnology | Series A | $9.4M | $286.7M | 2016 |
Jak Knowles at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jak Knowles on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ANDREW LEVIN | 1 | 17 |
| David Steinberg | 1 | 14 |
| Michael Kelly | 1 | 11 |
| Mark De Souza | 1 | 10 |
| Charles Bolten | 1 | 10 |
| Risa Stack | 1 | 9 |
| Christopher O'Donnell | 1 | 8 |
| Christoph Westphal | 1 | 8 |
| Geeta Vemuri | 1 | 7 |
| Mark P. De Souza | 1 | 7 |
| Robert Crane | 1 | 7 |
| Lucio Iannone | 1 | 6 |
| Brian Thomas | 1 | 5 |
| Derek Norman | 1 | 5 |
| John Peryam | 1 | 4 |
| Rick Holton | 1 | 4 |
| Andrew Farquharson | 1 | 4 |
| John Flavin | 1 | 4 |
| Michael P Kelly | 1 | 3 |
| Rick Holton, Jr. | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.